Oculis Holding AG - stock earnings
OCS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -19.0 million USD | ? USD |
| 2023Q2 | -14.3 million USD | ? USD |
| 2022Q4 | -9.9 million USD | ? USD |
| 2022Q3 | -10.2 million USD | ? USD |
| 2022Q2 | -12.9 million USD | ? USD |
| 2021Q4 | -6.1 million USD | ? USD |
| 2021Q3 | -5.3 million USD | ? USD |
OCS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -41.9 million USD | ? USD |
| 2021 | -20.3 million USD | ? USD |
| 2020 | -16.6 million USD | ? USD |
OCS
Price: $12.01
52 week price:
Earnings Per Share: -3.28 USD
P/E Ratio: -4.67
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 502.7 million